chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pretty bad anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Pretty bad anxiety) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced ANXIETY (Pretty bad anxiety). At the time of the report, ANXIETY (Pretty bad anxiety) had not resolved.            Patient reports not taking any concomitant medications. No treatment details were reported.
Hives and rash broke out over thighs and torso.  Also, I experienced muscle fatigue and aches.
Arm still hurts 2 days later. Extreme bruising. Lines similar to a person cutting themselves are on my arm.
Itching right after shot.  Swelling & redness.  Rt upper arm.
NOT FEELING WELL; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced not feeling well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of not feeling well was not reported. This report was non-serious.
vomiting; fever; malaise; abdominal pain; This spontaneous case was reported by a physician and describes the occurrence of VOMITING (vomiting), PYREXIA (fever), MALAISE (malaise) and ABDOMINAL PAIN (abdominal pain) in a 6-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 06-Oct-2023, the patient experienced VOMITING (vomiting), PYREXIA (fever), MALAISE (malaise) and ABDOMINAL PAIN (abdominal pain). At the time of the report, VOMITING (vomiting), PYREXIA (fever), MALAISE (malaise) and ABDOMINAL PAIN (abdominal pain) was resolving.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  It was unknown if the patient experienced any additional symptoms/events.  Treatment medications were not reported.
Kinrix at months 2 and 4 while under his care; Kinrix at months 2 and 4 while under his care; Kinrix at months 2 and 4 while under his care; was unwell; This case was reported by a physician via sales rep and described the occurrence of inappropriate age at vaccine administration in a 2-month-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix, Kinrix Pre-Filled Syringe Device, Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device and not applicable after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration, inappropriate age at vaccine administration, extra dose administered and malaise. On an unknown date, the outcome of the inappropriate age at vaccine administration, inappropriate age at vaccine administration, extra dose administered and malaise were unknown.   It was unknown if the reporter considered the malaise to be related to Kinrix and Kinrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The patient received Kinrix at months 2 and 4 while under his care (nurse administered doses), but then left the practice.  The reporter was not at all forthcoming with patient information, but stated that the patient's father was threatening to sue the practice and alluded to the fact that the patient was unwell.  He did not share how long ago the patient received Kinrix.
This spontaneous report was received from a pharmacist concerning a 51 year old female patient with a history of cervical disk problem who 22-AUG-2012 was vaccinated with a dose of ZOSTAVAX (lot number 672675/0068AE, expiration date 03-APR-2012) (route not provided). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on 23-AUG-2012, the patient experienced headaches after receiving an improperly store dose of ZOSTAVAX. The vaccine was exposed to 75 degrees F for 12 hours. She also mentioned that some of the solution leaked out from the syringe during the administration of ZOSTAVAX and the patient got some of the solution on their skin. The patient was given TYLENOL as treatment. On 24-AUG-2012, the patient recovered from the events. This is one of several reports received from the same source (Other case number 1209USA005351). Additional information has been requested.
He actually woke up with vomiting/ he threw up; Couldn't walk for a week; The room was spinning and he threw up; Rash over the body and it's on one side of the body right now the inside they're little balls,  bubbles with some kind of puss inside, water or puss; Rash over the body and it's on one side of the body right now the inside they're little balls,  bubbles with some kind of puss inside, water or puss; Not sure, we look at pictures they look like shingles; He has side effects on his left eye; This is a spontaneous report from a contactable consumer (parent). A 17-year-old male patient (reporter's son) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 03Jul2021 at around 10 at night (at the age of 17-year-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unknown date (Batch/Lot number was not reported) as single dose for covid-19 immunization and did not experience any adverse event. Reporter stated, "my son had the Pfizer and he in the states right now and he went to play hockey, he took the second COVID on the next Saturday, he got it around 10 o clock in the night on 03Jul2021 and on 04Jul2021 he actually woke up with vomiting, could not walk for a week, the room was spinning and he threw up, I don't know if I said that and barely made a back to the bedroom, woke up had a rash over the body and it was on one side of the body right now the inside they were little balls, bubbles with some kind of puss inside, water or puss". The reporter also stated "not sure, we look at pictures they look like shingles, I see on the internet that in some rare cases it can be activate shingles in your body and I want to know how rare these side effects are and what to do about it". When confirmed that the vaccine son took was Pfizer COVID-19 Vaccine, reporter stated, yes, he was 17 and he had to take it. When probed anatomical site where vaccine was administered, reporter stated, I don't know that. I know that he has side effects on his left eye (on an unknown date in Jul2021). I don't know what side he got the injection. I would assume you got it in his left hand because he uses his right hand for lot of things". The outcome of the events was unknown.  Information regarding the lot/batch number has been requested.
Patient received 2nd covid vaccine. no reactions to first one. about 15 min after 2nd vaccine, spouse noticed patient with puffy forehead. Patient knocked on clinic door and began to ask question. brought pt into the clinic. noticed mild erythema to forehead, and to bilat arms upper chest and slightly on mid back. at the time no itching or pain or shortness of breath.
Narrative: 7/26- covid positive; reports sore throat, dyspnea, cough 7/27- also reports chills, fatigue, headache, myalgia 8/4- improving, still reports fatigue and loss of taste/smell
Information has been received from a physician assistant concerning her 26 year old female friend with diagnosed cervical papilloma viral infection who in May 2008, was vaccinated with the first dose of GARDASIL.  There was no concomitant medication.  In approximately May 2008, "within the past two months" the patient developed genital warts.  The patient had had two outbreaks.  The outcome was unknown.  The patient contacted her physician to seek unspecified medical attention.  Follow-up information was received from the physician assistant stating that the patient was her personal friend and she did not see the patient in clinic.  Further information was unknown.  Additional information is not expected.
Swollen glands (5 days and still continuing ) Full body rash (2 days and still continuing)
Pain down arm 8 hours post injection. General malaise, fever, chills. Pain down influenza arm.
Shots given, Friday July16, right thigh red, swollen and tender to touch and warm. Shots on the yr, was no reaction.
I received the Shingrex shot on 5/9/2019 (NDC: 58160-0823-11). It was very painful and I sat for awhile as I was afraid I would get faint. Over 48 hours later, I developed a 2" swollen red area around the injection. By the next day, the area had expanded and I went to Urgent Care, where the doctor said it could be an infection or an allergic reaction and put me on both antihistamines and Keflex. By the next day the area had expanded to a 6" diameter and continued sore and swollen. I also continued shaking chills for several days, but no fever. It eventually mostly resolved although now, 2 weeks later, I can still feel a lump at the injection site. Because of the timing of of the local reaction, I believe it was an infection and not an allergic reaction and wonder whether the vaccine itself or the administration was contaminated.
maybe more tired than usual; muscle pain in the injection site area/ injection site is very sore; muscle pain in the injection site area/injection site is very sore/ injection site is very sore; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on [26Aug2021], this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient) via medical information team. This consumer reported for two patients. This is the one of two reports. A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), via intramuscular route, in left arm, on 25Aug2021 (at the age of 70-years-old), at dose 2, single for covid-19 immunization. Medical history included normally had muscle issues like osteoarthritis throughout her body which is ongoing; she normally has muscle issues, just not in the arm, always in the back, legs, and knees and went to a pain management doctor for epidurals and treatments for the issue, ongoing hypertension, ongoing cholesterol issues and had headaches every day; she is a migraine sufferer but didn't get any headaches at the day of report. The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), via an unspecified route, in left arm, on an unspecified date in 2021 (at the age of 70-years-old), at dose 1, single for covid-19 immunization. The patient experienced muscle pain in the injection site area/ injection site is very sore on 25Aug2021 and she maybe more tired than usual on 26Aug2021. The outcome of muscle pain in the injection site area was not recovered and outcome of the other event was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101110251 same reporter/drug/events with different patient
I have experienced loss of taste. Most notable in loss of salt taste; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8739) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00, (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, as prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for an unknown indication and since an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 23Mar2021 at 15:00 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 14:00, the patient experienced experienced loss of taste, most notable in loss of salt taste. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event loss of taste, most notable in loss of salt taste was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Day 2 post-vac: AM- Chills, headache, N/V, vertigo Day 2, PM: red spots on face, neck, stomach, leg, with low grade fever Day 3: mild headache, chest "tightness" Day 4: no complaint of discomfort  Patient was diagnosed with lab confirmed generalized vaccinia after vaccination with vaccinia in March, 2004. Pt now reports that she has had recurrent lesions over the last year since vaccination. They are usually few in number, may or may not be accompanied by systemic symptoms. Not certain if they become vessicula. Pt developed lesions on April 10. Were described as prurutic macules on forehead, both arms, left hand, foot, neck. The medical director for Schoharie County, Dr saw her on 4/13 and felt that the lesions were not able to be sampled. Blood was drawn on 4/16 and sent to Wadsworth lab on 4/19. It tested negative for vaccinia virus. Pt reports some aches and chillls. CDC hotline was called. It was suggested that the pt be seen by an immunologist or ID specialist in order to have an immune work-up. The patient is considering this action.
slight itching on trunk(abdomen, back, below breast); black and blue mark at the injection site; rash on trunk(abdomen, back, below breast); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (slight itching on trunk(abdomen, back, below breast)), VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site) and RASH (rash on trunk(abdomen, back, below breast)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and ALPHA LIPOIC ACID for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (slight itching on trunk(abdomen, back, below breast)), VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site) and RASH (rash on trunk(abdomen, back, below breast)). At the time of the report, PRURITUS (slight itching on trunk(abdomen, back, below breast)), VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site) and RASH (rash on trunk(abdomen, back, below breast)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment was unknown.
on the 2nd day;he had a little cold; On the 1st day, he felt Chest pain; passed out; feeling like I'm going to faint; stuffy nose; feel hot; Tachycardia; I felt like I was going to fade/last night he was feeling dizziness; hit my head on the wall and my back, it felt like I went into a black hole. I don't know for how long I was on the ground; nausea; He is experiencing blurry vision; headache; cough; Fatigue; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,  Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on 21Mar2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. He got the vaccine, the first Pfizer Covid vaccine he took on 21Mar2021 and at the moment he had to wait 15-20 minutes in that department. From there, he returned to his house and when he came home he began to feel hot, tachycardia, stuffy nose, he felt like he was going to fade, a lot of nausea, then he passed out and hit his head on the wall and his back, it felt like he went into a black hole. He did not know for how long he was on the ground, he then tried to get on the bed again. On the 1st day, he also felt chest pain and on the 2nd day, he had a little cold. He had cough, fatigue, nausea and blurry vision on unspecified date. They called medical facility, he went to a specialized doctor, he had me under observation for 2 days. Patient asked about the Pfizer's policy/recommendation regarding whether he should get the second shot or not. His second dose was scheduled for 13Apr2021. He continued with headaches and tachycardias, less frequent, as well as feeling like he was going to faint when he got up. Therapeutic measures were taken as a result of event "last night he was feeling dizziness". The outcome of headache, tachycardia and presyncope was not recovered and outcome of other events was unknown.  No follow up attempts are needed. No further information is expected.  Follow-up (11MAY2021): Follow-up attempts completed. No further information expected.
Information has been received from a registered nurse via a field representative referring to a male patient of unknown age. On an unspecified date approximately in 2015 (reported as "sometime in the last few weeks") the patient was vaccinated with GARDASIL 9, strength and dose number of the 3rd dose series unspecified, 0.5 ml once, intramuscularly as HPV Vaccination. About the same time, the patients were also given concomitant therapies included TDAP and meningococcal vaccine (unspecified). On an unspecified date in 2015 the patient experienced severe nausea after receiving GARDASIL 9 vaccine. The outcome of nausea and the causality were not provided. This is one of several reports received from the same reporter. Additional information has been requested.
pt states  RD red, swollen noc of inj;morning of 2APR pt states had fever (chills-sweating) did not take temp-had to leave work & go home d/t fever & pain;advised by MD to take Ibuprofen & hot soaks;
3 days after i receivd TDAP vaccine, i noticed a sudden change of sensitivity in my left hand, and soon it got very swelled and feeling that it did not respond to my orders but the three left fingers lost all feelings, and falled below the other fingers. This situation has receded to a 50% swellnes but still has this funny feeling that my fingers dont obey to my orders. i lost my grip to hold things, and now it is impozible to type my pc using my left hand.
When I take the shot I'm sick as hell for a week or more; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 22-Nov-2020.  This case involves a patient of unknown demographics, when patient took the shot got sick as hell for a week or more (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.   On an unknown date, the patient reported that when patient took the shot got sick as hell for a week or more (illness) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE. Full blown Flu, it's done in 1-2 days, with much milder symptoms. With everything patient have been reading, damn sure won't be getting it this year.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Patient reported and adverse reaction to his first pfizer dose received on 10/26/21.  He stated two days later the left side of his face started to feel numb.  He went to the hospital.  They tested him with no finding and sent him home with a referral to neurology.  The symptoms resolved on their own by the next morning.
COVID booster; COVID vaccine administered concurrently with flu vaccine; Low grade fever; soreness at injection site; lack of sleep following COVID booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3, (booster) single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU VACCINE VII taken for immunisation. Vaccination history included: Covid-19 vaccine (Dose:1, Manfacturer- Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose:2, Manfacturer- Unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "COVID booster"; PRODUCT USE ISSUE (non-serious), outcome "unknown", described as "COVID vaccine administered concurrently with flu vaccine"; PYREXIA (non-serious), outcome "unknown", described as "Low grade fever"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "soreness at injection site"; SLEEP DISORDER (non-serious), outcome "unknown", described as "lack of sleep following COVID booster". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.